Axsome shares surge 75% after depression drug reduces symptoms in late-stage study

Axsome shares surge 75% after depression drug reduces symptoms in late-stage study
Reuters: Health
Axsome Therapeutics Inc said on Monday its drug succeeded in reducing symptoms of major depressive disorder in a late-stage trial, taking the company a step closer to entering a multi-billion dollar market for depression treatments.